Holen Sie sich die Stockscreener-App
0.00
100.00%
-8.68
Schlusskurs vom Vortag:
$8.68
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$544.94M
Einnahmen:
$91.06M
Nettoeinkommen (Verlust:
$-503.14M
KGV:
0.00
EPS:
-8.39
Netto-Cashflow:
$-424.74M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$9.36
Sage Therapeutics Inc Stock (SAGE) Company Profile
Firmenname
Sage Therapeutics Inc
Sektor
Branche
Telefon
617-299-8380
Adresse
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Vergleichen Sie SAGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SAGE
Sage Therapeutics Inc
|
0.00 | 544.94M | 91.06M | -503.14M | -424.74M | -8.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.13 | 98.23B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
595.73 | 62.74B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.92 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
740.03 | 45.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
337.81 | 36.81B | 3.81B | -644.79M | -669.77M | -6.24 |
Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-11 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-21 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2024-10-10 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-10-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-07-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-29 | Eingeleitet | Citigroup | Sell |
| 2024-05-29 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-17 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Hold |
| 2023-08-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-08-08 | Herabstufung | Goldman | Buy → Neutral |
| 2023-08-08 | Herabstufung | Needham | Buy → Hold |
| 2023-08-07 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-08-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-08-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-08-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-03-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-11-01 | Eingeleitet | Loop Capital | Hold |
| 2022-03-31 | Eingeleitet | Berenberg | Hold |
| 2021-11-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-06-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-07 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-02-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-02-02 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-01-22 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-01-04 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-04 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-12-01 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-06 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-09-11 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-08-10 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-04-08 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-18 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-28 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-06 | Eingeleitet | Mizuho | Neutral |
| 2019-12-06 | Bestätigt | RBC Capital Mkts | Outperform |
| 2019-12-05 | Bestätigt | Guggenheim | Buy |
| 2019-12-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-10-30 | Eingeleitet | H.C. Wainwright | Neutral |
| 2019-05-23 | Eingeleitet | Wedbush | Outperform |
| 2019-04-25 | Eingeleitet | Jefferies | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Outperform |
| 2018-10-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Sage Therapeutics Inc Aktie (SAGE) Neueste Nachrichten
Volatility clustering patterns for Sage Therapeutics Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
ETF Watch: Is Sage Therapeutics Inc impacted by rising ratesMarket Performance Recap & Safe Capital Investment Plans - خودرو بانک
Guidance Update: Can Sage Therapeutics Inc maintain sales growthPortfolio Performance Report & Fast Gain Stock Trading Tips - خودرو بانک
Macro Review: Why is Sage Therapeutics Inc stock going upQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - خودرو بانک
Market Catalysts: How cyclical is Sage Therapeutics Inc.’s revenue streamBull Run & Breakout Confirmation Alerts - خودرو بانک
Rate Cut: Is LCNB Corp still a buy after recent gainsShare Buyback & Weekly Stock Performance Updates - khodrobank.com
Guidance Update: What are the future prospects of Sage Therapeutics IncWeekly Stock Recap & Expert Curated Trade Setup Alerts - خودرو بانک
Exit Recap: Why is Sage Therapeutics Inc stock going up2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Gainers Report: Will Sage Therapeutics Inc. benefit from current market trendsPortfolio Growth Summary & Weekly Chart Analysis and Guides - خودرو بانک
Gainers Report: Can DSS Inc outperform under higher oil pricesQuarterly Market Summary & Daily Stock Trend Reports - خودرو بانک
Aug Ideas: Can Sage Therapeutics Inc. reach resistance levels soonJuly 2025 Snapshot & Stock Portfolio Risk Management - خودرو بانک
Institution Moves: What are Sage Therapeutics Inc.’s technical support levelsWall Street Watch & Low Risk Entry Point Tips - خودرو بانک
Chipmakers Recap: What are the future prospects of Sage Therapeutics IncWeekly Investment Summary & Weekly Top Gainers Alerts - خودرو بانک
Surprises Report: Can Sage Therapeutics Inc deliver consistent dividendsGlobal Markets & Daily Chart Pattern Signals - خودرو بانک
Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - MSN
Published on: 2025-09-08 15:36:12 - beatles.ru
Can Traders Expect Breakout From Sage Therapeutics Inc. This Week2025 Institutional Moves & Reliable Momentum Entry Alerts - beatles.ru
How cyclical is Sage Therapeutics Inc.’s revenue stream2025 Sector Review & Real-Time Price Movement Reports - beatles.ru
Applying Elliott Wave Theory to Sage Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Will Sage Therapeutics Inc. benefit from current market trendsMarket Rally & Low Risk Entry Point Tips - خودرو بانک
Will breakout in Sage Therapeutics Inc. lead to full recoveryJuly 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser
Will Sage Therapeutics Inc. stock go up in YEARMarket Movement Recap & Consistent Income Trade Ideas - خودرو بانک
Is Sage Therapeutics Inc. stock undervalued right nowRecession Risk & Free Fast Gain Swing Trade Alerts - خودرو بانک
Will Sage Therapeutics Inc. be affected by tariffsSwing Trade & Technical Entry and Exit Alerts - خودرو بانک
Can Sage Therapeutics Inc. sustain its profitabilityQuarterly Profit Review & Growth Focused Entry Point Reports - خودرو بانک
Inflation Data: Can Sage Therapeutics Inc. sustain its profitability2025 Market Outlook & Weekly Stock Breakout Alerts - خودرو بانک
Does Palvella Therapeutics Inc. have strong EBITDA marginsMarket Sentiment Report & Technical Pattern Based Buy Signals - خودرو بانک
Visualizing Sage Therapeutics Inc. stock with heatmapsWeekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Is Sage Therapeutics Inc. exposed to currency risksWeekly Trade Summary & Stock Timing and Entry Methods - خودرو بانک
Layoff Tracker: Novo Cuts 9,000 Employees, Including 5,000 in Denmark - BioSpace
What the charts say about Sage Therapeutics Inc. todayEarnings Recap Summary & Growth Focused Stock Pick Reports - Newser
Can Sage Therapeutics Inc. reach all time highs this yearJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - خودرو بانک
Supernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage Therapeutics - MSN
Combining machine learning predictions for Sage Therapeutics Inc.Weekly Trend Summary & AI Based Trade Execution Alerts - Newser
Top chart patterns to watch in Sage Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - Newser
Can momentum traders help lift Sage Therapeutics Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
Developing predictive dashboards with Sage Therapeutics Inc. dataJuly 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Why is Sage Therapeutics Inc. stock going upPortfolio Performance Summary & Daily Stock Trend Watchlist - خودرو بانک
Big Money Moves: Can Sage Therapeutics Inc. reach resistance levels soonQuarterly Trade Report & Low Risk Investment Opportunities - خودرو بانک
How to forecast Sage Therapeutics Inc. trends using time seriesWeekly Investment Recap & Smart Investment Allocation Tips - Newser
Live market analysis of Sage Therapeutics Inc.July 2025 Action & Smart Swing Trading Techniques - Newser
What are Sage Therapeutics Inc.’s technical support levels2025 Dividend Review & AI Forecasted Entry and Exit Points - خودرو بانک
Should you hold or exit Sage Therapeutics Inc. nowEarnings Summary Report & Safe Capital Growth Stock Tips - Newser
Analyzing Sage Therapeutics Inc. with multi timeframe charts2025 Risk Factors & Expert Approved Momentum Ideas - Newser
Market reaction to Sage Therapeutics Inc.’s recent newsDay Trade & Weekly Return Optimization Plans - Newser
Is it too late to sell Sage Therapeutics Inc.Earnings Recap Report & Technical Confirmation Trade Alerts - Newser
Best data tools to analyze Sage Therapeutics Inc. stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Will Sage Therapeutics Inc. benefit from green energy policiesLayoff News & Community Verified Trade Signals - خودرو بانک
MACD Cross Could Confirm Trend in Sage Therapeutics Inc.2025 Fundamental Recap & Verified Stock Trade Ideas - beatles.ru
Will Sage Therapeutics Inc. rebound enough to break evenJuly 2025 Selloffs & Risk Managed Investment Signals - Newser
Investors in Sage Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your RightsSAGE - ACCESS Newswire
Finanzdaten der Sage Therapeutics Inc-Aktie (SAGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):